Brief: Iterum Therapeutics Reports Q3 2022 Results
10/11/2022 12:28
Nov 10 (Reuters) - Iterum Therapeutics Plc ITRM.O :
* ITERUM THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
* QTRLY LOSS PER SHARE $2.38
* QTRLY ADJUSTED LOSS PER SHARE $0.43
Source text for Eikon: ID:nGNX7P6kRh
Further company coverage: ITRM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Iterum Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Entergy, US natgas stocks, Brown-Forman, Datacentrex
U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services
Iterum Therapeutics plummets after filing wind up petition
Iterum seeks court-led dissolution amid cash crisis, inability to raise funds (updated)
Iterum files wind-up petition due to limited cash, inability to raise equity